BR112012014770A2 - derivados de etinila - Google Patents
derivados de etinilaInfo
- Publication number
- BR112012014770A2 BR112012014770A2 BR112012014770A BR112012014770A BR112012014770A2 BR 112012014770 A2 BR112012014770 A2 BR 112012014770A2 BR 112012014770 A BR112012014770 A BR 112012014770A BR 112012014770 A BR112012014770 A BR 112012014770A BR 112012014770 A2 BR112012014770 A2 BR 112012014770A2
- Authority
- BR
- Brazil
- Prior art keywords
- ethinyl
- derivatives
- ethinyl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09179719 | 2009-12-17 | ||
PCT/EP2010/069593 WO2011073172A1 (en) | 2009-12-17 | 2010-12-14 | Ethynyl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012014770A2 true BR112012014770A2 (pt) | 2016-03-29 |
Family
ID=43446449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012014770A BR112012014770A2 (pt) | 2009-12-17 | 2010-12-14 | derivados de etinila |
Country Status (27)
Country | Link |
---|---|
US (2) | US8586581B2 (pt) |
EP (1) | EP2513102B1 (pt) |
JP (1) | JP5763094B2 (pt) |
KR (1) | KR101407856B1 (pt) |
CN (1) | CN102686589B (pt) |
AR (1) | AR079467A1 (pt) |
AU (1) | AU2010332987B2 (pt) |
BR (1) | BR112012014770A2 (pt) |
CA (1) | CA2780155A1 (pt) |
CL (1) | CL2012001596A1 (pt) |
CO (1) | CO6531478A2 (pt) |
CR (1) | CR20120269A (pt) |
EC (1) | ECSP12011977A (pt) |
ES (1) | ES2551582T3 (pt) |
HK (1) | HK1171225A1 (pt) |
IL (1) | IL219371A (pt) |
MA (1) | MA33802B1 (pt) |
MX (1) | MX2012006789A (pt) |
MY (1) | MY162998A (pt) |
NZ (1) | NZ599553A (pt) |
PE (1) | PE20121443A1 (pt) |
RU (1) | RU2553461C2 (pt) |
SG (1) | SG181779A1 (pt) |
TW (1) | TWI448465B (pt) |
UA (1) | UA107002C2 (pt) |
WO (1) | WO2011073172A1 (pt) |
ZA (1) | ZA201204429B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103980129B (zh) * | 2010-11-05 | 2016-08-31 | 日本欧爱特农业科技株式会社 | 乙炔基苯脒化合物或其盐、其制备方法和用于农业和园艺的杀菌剂 |
DK2702051T3 (en) | 2011-04-26 | 2015-03-16 | Hoffmann La Roche | Ethynyl derivatives AS POSITIVE allosteric modulators mGluR5 |
US20130123254A1 (en) | 2011-09-30 | 2013-05-16 | Barbara Biemans | Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
UA110862C2 (uk) * | 2011-10-07 | 2016-02-25 | Ф. Хоффманн-Ля Рош Аг | Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5 |
PL2900659T3 (pl) * | 2012-09-27 | 2017-02-28 | F.Hoffmann-La Roche Ag | Pochodne aryloetynylowe |
AU2013331782B2 (en) * | 2012-10-18 | 2017-03-09 | F. Hoffmann-La Roche Ag | Ethynyl derivatives as modulators of mGluR5 receptor activity |
BR112015009649A2 (pt) * | 2012-11-07 | 2017-07-04 | Hoffmann La Roche | composto de triazolo |
CR20170536A (es) | 2015-06-03 | 2018-02-01 | Hoffmann La Roche | Derivados de etinilo |
MA42442B1 (fr) | 2015-07-15 | 2019-07-31 | Hoffmann La Roche | Dérivés d'éthynyle comme modulateurs du récepteur métabotropique au glutamate |
RU2745068C2 (ru) | 2016-07-18 | 2021-03-18 | Ф. Хоффманн-Ля Рош Аг | Производные этинила |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1117403T3 (da) * | 1998-10-02 | 2004-04-13 | Sibia Neurosciences Inc | MGLUR5-antagonister til behandling af smerte og angst |
AR029803A1 (es) | 2000-02-21 | 2003-07-16 | Smithkline Beecham Plc | Imidazoles sustituidos con piridilo y composiciones farmaceuticas que las comprenden |
GB0027987D0 (en) * | 2000-11-16 | 2001-01-03 | Smithkline Beecham Plc | Compounds |
US6910976B2 (en) | 2001-06-26 | 2005-06-28 | Stx, Llc | Multi-component lacrosse stick head |
GB0127430D0 (en) * | 2001-11-15 | 2002-01-09 | Smithkline Beecham Corp | Compounds |
GB0127433D0 (en) * | 2001-11-15 | 2002-01-09 | Smithkline Beecham Corp | Compounds |
TWI292318B (en) * | 2003-03-10 | 2008-01-11 | Hoffmann La Roche | Imidazol-4-yl-ethynyl-pyridine derivatives |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
GB0413605D0 (en) | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
EP1809620B1 (en) | 2004-11-04 | 2010-12-29 | Addex Pharma SA | Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
EP2308870A3 (en) * | 2005-06-01 | 2011-10-19 | UCB Pharma S.A. | 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
CA2632194C (en) | 2005-11-15 | 2012-01-03 | Array Biopharma Inc. | N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
MX2008016523A (es) | 2006-06-30 | 2009-01-19 | Astrazeneca Ab | Derivados de pirimidina utiles en el tratamiento de cancer. |
EP1972628A1 (en) | 2007-03-21 | 2008-09-24 | Schwarz Pharma Ag | Indolizines and aza-analog derivatives thereof as CNS active compounds |
US8076344B2 (en) * | 2007-04-30 | 2011-12-13 | Abbott Laboratories | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
EA200971143A1 (ru) | 2007-06-03 | 2010-06-30 | Вандербилт Юниверсити | Бензамидные mglur5 позитивные аллостерические модуляторы и способы их получения и применения |
TW201116532A (en) * | 2009-08-05 | 2011-05-16 | Merz Pharma Gmbh & Co Kgaa | Metabotropic glutamate receptor modulators |
-
2010
- 2010-12-10 US US12/964,785 patent/US8586581B2/en not_active Expired - Fee Related
- 2010-12-14 CN CN201080057081.9A patent/CN102686589B/zh not_active Expired - Fee Related
- 2010-12-14 UA UAA201207427A patent/UA107002C2/uk unknown
- 2010-12-14 MY MYPI2012002710A patent/MY162998A/en unknown
- 2010-12-14 CA CA2780155A patent/CA2780155A1/en not_active Abandoned
- 2010-12-14 NZ NZ599553A patent/NZ599553A/en not_active IP Right Cessation
- 2010-12-14 SG SG2012044814A patent/SG181779A1/en unknown
- 2010-12-14 ES ES10790960.8T patent/ES2551582T3/es active Active
- 2010-12-14 RU RU2012128551/04A patent/RU2553461C2/ru not_active IP Right Cessation
- 2010-12-14 WO PCT/EP2010/069593 patent/WO2011073172A1/en active Application Filing
- 2010-12-14 EP EP10790960.8A patent/EP2513102B1/en not_active Not-in-force
- 2010-12-14 AU AU2010332987A patent/AU2010332987B2/en not_active Ceased
- 2010-12-14 JP JP2012543676A patent/JP5763094B2/ja not_active Expired - Fee Related
- 2010-12-14 TW TW099143811A patent/TWI448465B/zh not_active IP Right Cessation
- 2010-12-14 KR KR1020127018589A patent/KR101407856B1/ko not_active IP Right Cessation
- 2010-12-14 MX MX2012006789A patent/MX2012006789A/es active IP Right Grant
- 2010-12-14 BR BR112012014770A patent/BR112012014770A2/pt not_active Application Discontinuation
- 2010-12-14 PE PE2012000817A patent/PE20121443A1/es not_active Application Discontinuation
- 2010-12-15 AR ARP100104641A patent/AR079467A1/es unknown
-
2012
- 2012-04-23 IL IL219371A patent/IL219371A/en not_active IP Right Cessation
- 2012-04-25 CO CO12068169A patent/CO6531478A2/es active IP Right Grant
- 2012-05-22 CR CR20120269A patent/CR20120269A/es unknown
- 2012-05-24 MA MA34890A patent/MA33802B1/fr unknown
- 2012-06-14 CL CL2012001596A patent/CL2012001596A1/es unknown
- 2012-06-15 EC ECSP12011977 patent/ECSP12011977A/es unknown
- 2012-06-15 ZA ZA2012/04429A patent/ZA201204429B/en unknown
- 2012-11-23 HK HK12112004.5A patent/HK1171225A1/xx not_active IP Right Cessation
-
2013
- 2013-10-16 US US14/055,047 patent/US8933094B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1013246A2 (pt) | derivados de benzofuralina | |
BR112012002828A2 (pt) | derivados de 5-fluorpirimidinona | |
BRPI1013844A2 (pt) | derivados de piridina-isoxazol | |
BRPI1008749A2 (pt) | Derivados de benzodiazepina | |
ECSP12011999A (es) | Derivados benzamida sustituidos | |
BR112012015868A2 (pt) | derivados de imidazolidinadiona | |
BRPI1006128A2 (pt) | derivados de sulfonamida | |
BRPI1008774A2 (pt) | espiroamida substituída | |
BRPI1012770A2 (pt) | derivados de tiofeno | |
BRPI1011468A2 (pt) | derivados condensados de pirrolipiridino | |
BRPI1013614A2 (pt) | compostos substituídos de espiro-amida | |
BRPI0913832A2 (pt) | derivados de pirrolopiridinilpirimidin-2-ilamina | |
BRPI0915064A2 (pt) | derivados de qunoxalinadiona | |
BRPI1005525A2 (pt) | compostos de azaazuleno | |
DK2397480T3 (da) | Diazepindionderivat | |
BR112012008108A2 (pt) | derivados de xantina substituídos | |
BRPI1014454A2 (pt) | derivados de isoxazol-pirazol | |
BR112012014770A2 (pt) | derivados de etinila | |
BR112012010242A2 (pt) | derivados de heteroarilpiperidina e heteroarilpiperazina | |
DK2387580T3 (da) | Deoxyactagardinderivater | |
BRPI0913234A2 (pt) | derivados de tiazolilpiperidina | |
BRPI1007884A2 (pt) | derivados de actagardina | |
BR112012002810A2 (pt) | derivados de n1-acil-5-fluoropirimidinona | |
BR112012016923A2 (pt) | Derivados de pirazol | |
BR112012005503A2 (pt) | derivados de isoxazolidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |